Senior Vice President, Regulatory Affairs.

Dr. Harris Rotman joined Centessa in July 2022 as Senior Vice President, Regulatory Affairs. Dr. Rotman has over twenty years of pharmaceutical industry experience with an additional eight years of scientific research training. He has experience liaising with various regulatory agencies, and is proficient in investigational development, post-approval activities, application maintenance, advertising/promotion review, and medical writing. Dr. Rotman has managed multiple worldwide developmental projects for regulatory in neuroscience, cardiovascular, renal, dermatologic, analgesic, addiction, aesthetic, and gastrointestinal therapeutic areas, including rare/orphan disease products. He has worked at Wyeth, Sanofi, Shire, Indivior, Endo, and SwanBio Therapeutics.

Dr. Rotman received his BS in Biological Sciences from Rutgers University and PhD in Microbiology and Molecular Virology from Thomas Jefferson University. He then did his Postdoctoral Fellowship at Hahnemann University Hospital.